Flc Capital Advisors Eli Lilly & CO Transaction History

Flc Capital Advisors

$430 Million
Q3 2024

A detailed history of Flc Capital Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Flc Capital Advisors holds 1,129 shares of LLY stock, worth $844,503. This represents 0.23% of its overall portfolio holdings.

Number of Shares

1,129

Previous 1,139 0.88%

Holding current value

$844,503

Previous $1.03 Million 3.01%

% of portfolio

0.23%

Previous 0.25%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$772.14 - $960.02 $7,721 - $9,600	-10 Reduced 0.88%	1,129 $1 Million
Q2 2024 Jul 15, 2024	SELL	$724.87 - $909.04 $32,619 - $40,906	-45 Reduced 3.8%	1,139 $1.03 Million
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $10,659 - $14,261	-18 Reduced 1.5%	1,184 $921,000
Q3 2023 Jan 18, 2024	SELL	$434.7 - $599.3 $28,690 - $39,553	-66 Reduced 5.21%	1,202 $645,000
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $3,507 - $4,689	-10 Reduced 0.78%	1,268 $594,000
Q4 2022 Jan 27, 2023	SELL	$321.55 - $374.67 $5,787 - $6,744	-18 Reduced 1.39%	1,278 $467,000
Q3 2022 Oct 14, 2022	SELL	$296.48 - $337.87 $138,456 - $157,785	-467 Reduced 26.49%	1,296 $419,000
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $16,432 - $21,272	-100 Reduced 5.37%	1,763 $329,000
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $243,046 - $321,609	1,863 New	1,863 $315,000
Q2 2020 Jul 10, 2020	SELL	$136.42 - $164.18 $210,086 - $252,837	-1,540 Closed	0 $0
Q1 2020 Apr 09, 2020	BUY	$119.05 - $147.35 $183,337 - $226,919	1,540 New	1,540 $219,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flc Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Flc Capital Advisors with notifications on news.

Account

Flc Capital Advisors Eli Lilly & CO Transaction History